First oral short-course treatment for highly active relapsing multiple sclerosis (RMS) now approved in Europe
Category: Online First
The Missing Pieces: Identifying the gaps in care and conversations in MS
Developed and funded by Sanofi Genzyme
Life After Encephalitis: Ross’s Story
Ross’s story: An excerpt from “Life after Encephalitis” by Dr Ava Easton.
The Encephalitis Society
Dr Ava Easton
Sponsored Article
STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common…
